Found 4 results
↓ CSVName | Type of Offering | Accepted Date |
---|---|---|
N30 Pharmaceuticals, Inc.
See All Filings
|
D | 2014-11-24 |
Amount To Be Raised
$40,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001626199
Filed Document
0001626199-14-000001
Exclusions or Exemptions
506b
Accepted Date
2014-11-24
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
COLORADO
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
ALPINE IMMUNE SCIENCES, INC.
See All Filings
|
D | 2019-01-30 15:09:11 |
Amount To Be Raised
$48,660,651
Associated Brokers / Dealers
N/A
CIK Number
0001626199
Filed Document
0001626199-19-000001
Exclusions or Exemptions
506b
Accepted Date
2019-01-30 15:09:11
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
WASHINGTON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
ALPINE IMMUNE SCIENCES, INC.
See All Filings
|
D | 2020-08-07 14:20:30 |
Amount To Be Raised
$82,666,486
Associated Brokers / Dealers
N/A
CIK Number
0001626199
Filed Document
0001626199-20-000038
Exclusions or Exemptions
506b
Accepted Date
2020-08-07 14:20:30
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
WASHINGTON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
ALPINE IMMUNE SCIENCES, INC.
See All Filings
|
D | 2021-09-29 16:23:50 |
Amount To Be Raised
$91,003,125
Associated Brokers / Dealers
N/A
CIK Number
0001626199
Filed Document
0001626199-21-000132
Exclusions or Exemptions
506b
Accepted Date
2021-09-29 16:23:50
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
WASHINGTON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|